Company Filing History:
Years Active: 2013-2019
Title: The Innovative Contributions of Sophie Descamps
Introduction
Sophie Descamps is a notable inventor based in Belbeuf, France, recognized for her significant contributions to the field of pharmaceuticals. With two patents to her name, she has made substantial strides in developing novel compounds aimed at treating serious health conditions, particularly cancer.
Latest Patents
Sophie Descamps holds patents for two groundbreaking inventions. The first patent involves substituted 4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrazine derivatives and 5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a][1,4]diazepine derivatives, which serve as ROS1 inhibitors. This invention includes detailed methodologies for preparing these compounds, highlighting their utility in pharmaceutical compositions as active ingredients. The second patent focuses on indole derivatives as anticancer agents, offering innovative compounds for cancer treatment and supporting the development of effective pharmaceutical formulations.
Career Highlights
Sophie is currently affiliated with Janssen Pharmaceutica NV, a prominent company engaged in the research and development of pharmaceutical products. Her work contributes to advancing therapeutic options for patients facing challenging medical conditions.
Collaborations
In her research endeavors, Sophie collaborates with esteemed colleagues including Laurence Anne Mevellec and Elisabeth Therese Jeanne Pasquier. These professional relationships enhance her innovative output and promote a dynamic approach to pharmaceutical research.
Conclusion
Sophie Descamps exemplifies the spirit of innovation within the pharmaceutical industry. Her patents reflect a commitment to addressing critical health challenges through thoughtful research and development. As she continues her work at Janssen Pharmaceutica NV, her contributions will undoubtedly influence future advancements in medical science.